Evidence map›Paper›PMID 40980314›Full record

ArticleFrontiers in microbiology2025

Machine learning-based high-specificity diagnostic model for

Yingjun Xiao, Xiling Chen, Xiping Ou, Zheqing Dong, Xiaoyan Zhang, Wei Liang, Xiaojing Nan, Chan Xu, Xiaobo Lai, Peng Xu and 1 more

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yingjun Xiao *The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Xiling Chen *The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Xiping Ou *The Third School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Zheqing DongThe Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Xiaoyan ZhangThe First People's Hospital of Yuhang District, Hangzhou, Zhejiang, China.
Wei LiangLuqiao Hospital of Traditional Chinese Medicine, Taizhou, Zhejiang, China.
Xiaojing NanThe Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Chan XuThe Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Xiaobo LaiSchool of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Peng XuThe Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Kui FangThe Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study developed and validated a machine learning (ML)-based predictive model utilizing febrile patients' routine clinical laboratory data for the purpose of screening such patients for Methods: This retrospective study enrolled febrile patients who visited Zhejiang Provincial People's Hospital and the Third Affiliated Hospital of Zhejiang Chinese Medical University from January 2021-April 2025. Patient data, including sex, age, and laboratory test results, were collected. Through sparse partial least squares discriminant analysis, the most informative features were extracted from the dataset. Six classic machine learning algorithms were utilized to develop the optimal predictive model through 1000 bootstrap resamplings. Finally, the model was validated on an independent clinical validation dataset. Results: The training dataset comprised 485 febrile patients (141 with Conclusion: A random forest model can effectively utilize routine clinical laboratory data to predict

Indexed as

feature miningfebrile patientsmachine learningpredictive modelTalaromyces marneffei

Identifiers

PMID40980314
PMCPMC12443677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.